Trademark Search in Canada

UROCIT-K

View On IC.GC.CA

REGISTERED

on 17 Feb 2005

Last Applicant/ Owned by

MISSION PHARMACAL COMPANY

10999 IH-10 WestTexas, San Antonio 78230

Serial Number

1168967 filed on 24^th Feb 2003

Registration Number

TMA633026 registered on 17^th Feb 2005

Registration expiry Date

17^th Feb 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

UROCIT-K

Trademark usage description

pharmaceutical preparation that is a prophylactic and treatment drug of potassium citrate embodied in a slow-release wax matrix to prevent or dissolve Read More

Classification Information

Class [005]
Pharmaceutical preparation that is a prophylactic and treatment drug of potassium citrate embodied in a slow-release wax matrix to prevent or dissolve kidney stones.

Classification kind code

Mark Details

Serial Number

1168967

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 55 on 17^th Feb 2005	Registered
Submitted for opposition 50 on 30^th Jul 2004	Allowed
Submitted for opposition 51 on 30^th Jul 2004	Allowance Notice Sent
Submitted for opposition 42 on 12^th May 2004	Advertised
Submitted for opposition 26 on 7^th Apr 2004	Approved
Submitted for opposition 22 on 17^th Nov 2003	Search Recorded
Submitted for opposition 20 on 17^th Nov 2003	Examiner's First Report
Submitted for opposition 31 on 7^th Mar 2003	Formalized
Submitted for opposition 1 on 27^th Feb 2003	Created
Submitted for opposition 30 on 24^th Feb 2003	Filed

UROCIT-K

Classification Information

Class [005]Pharmaceutical preparation that is a prophylactic and treatment drug of potassium citrate embodied in a slow-release wax matrix to prevent or dissolve kidney stones.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparation that is a prophylactic and treatment drug of potassium citrate embodied in a slow-release wax matrix to prevent or dissolve kidney stones.